Fangbo Cui
Impact in
- Biomaterials top 10%
- Nanoparticle-Based Drug Delivery
- Silk-based biomaterials and applications
- Electrospun Nanofibers in Biomedical Applications
-
- Nanoplatforms for cancer theranostics
- Graphene and Nanomaterials Applications
Papers in
-
- RNA Interference and Gene Delivery 3
- Advanced biosensing and bioanalysis techniques 2
- Histone Deacetylase Inhibitors Research 1
-
- Nanoparticle-Based Drug Delivery 2
- Co-authors
- Rutian Li (5 shared papers)Xianfeng Zhang (1 shared paper)Xuezhong Du (1 shared paper)Baorui Liu (4 shared papers)Lixia Yu (4 shared papers)Xiaoping Qian (4 shared papers)Puyuan Wu (4 shared papers)Guofeng Yue (4 shared papers)
In The Last Decade
Fangbo Cui
10 papers receiving 356 citations
Peers
Comparison fields: 5 of 68
- Biomaterials 175
- Biomedical Engineering 145
- Biotechnology 21
- Molecular Biology 161
- Cancer Research 34
Countries citing papers authored by Fangbo Cui
This map shows the geographic impact of Fangbo Cui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangbo Cui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangbo Cui more than expected).
Fields of papers citing papers by Fangbo Cui
This network shows the impact of papers produced by Fangbo Cui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangbo Cui. The network helps show where Fangbo Cui may publish in the future.
Co-authors
The 25 scholars most cited alongside Fangbo Cui, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 80 | |
| 2 | 2018 | 78 | |
| 3 | 2013 | 64 | |
| 4 | 2013 | 49 | |
| 5 | 2014 | 31 | |
| 6 | 2015 | 26 | |
| 7 | 2017 | 17 | |
| 8 | 2018 | 6 | |
| 9 | 2012 | 6 | |
| 10 | 2016 | 2 |
About Fangbo Cui
Fangbo Cui is a scholar working on Molecular Biology, Biomaterials, Biotechnology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 10 papers that have together received 359 indexed citations. Recurring topics across this work include Cancer Research and Treatments (4 papers), Nanoplatforms for cancer theranostics (3 papers), RNA Interference and Gene Delivery (3 papers), Advanced biosensing and bioanalysis techniques (2 papers), Nanoparticle-Based Drug Delivery (2 papers), Cancer Genomics and Diagnostics (1 paper), MicroRNA in disease regulation (1 paper) and Histone Deacetylase Inhibitors Research (1 paper). The work is most often cited by research in Biomaterials (175 citations), Biomedical Engineering (145 citations), Biotechnology (21 citations), Molecular Biology (161 citations) and Cancer Research (34 citations). Fangbo Cui has collaborated with scholars based in China, Hong Kong and Canada. Frequent co-authors include Rutian Li, Xianfeng Zhang, Xuezhong Du, Baorui Liu, Lixia Yu, Xiaoping Qian, Puyuan Wu, Guofeng Yue, Fenglei Wu and Xia Sun. Their work appears in journals such as International Journal of Nanomedicine, Cancer Letters, Oncotarget, Small and ACS Applied Materials & Interfaces.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.